{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:24:43Z","timestamp":1788305083990,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PS 15\/00616"],"award-info":[{"award-number":["PS 15\/00616"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0627-z","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T08:34:49Z","timestamp":1493800489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Marcio","family":"Andrade-Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Irun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Rosario","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Luis","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Angeles","family":"Fernandez-Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gracia-Antequera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lendinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Madruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Martin-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Mar","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto P\u00e9rez","family":"del Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda Ruiz","family":"del Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Sancho-Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Sanjurjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pocovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"issue":"4","key":"627_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000131781","volume":"33","author":"EA Devine","year":"1982","unstructured":"Devine EA, Smith M, Arredondo-Vega FX, Shafit-Zagardo B, Desnick RJ. Regional assignment of the structural gene for human acid beta-glucosidase to q42 leads to qter on chromosome 1. Cytogenet Cell Genet. 1982;33(4):340\u20134.","journal-title":"Cytogenet Cell Genet"},{"issue":"Suppl 3","key":"627_CR2","first-page":"37","volume":"129","author":"A Mehta","year":"2007","unstructured":"Mehta A. Gaucher disease. Lijec Vjesn. 2007;129 Suppl 3:37.","journal-title":"Lijec Vjesn"},{"issue":"3","key":"627_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6","volume":"8","author":"E Beutler","year":"1996","unstructured":"Beutler E, Gelbart T. Glucocerebrosidase (Gaucher disease). Hum Mutat. 1996;8(3):207\u201313.","journal-title":"Hum Mutat"},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","volume":"18","author":"RO Brady","year":"1965","unstructured":"Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease. Biochem Biophys Res Commun. 1965;18:221\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"627_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","volume":"83","author":"E Sidransky","year":"2004","unstructured":"Sidransky E. Gaucher disease: complexity in a \u201csimple\u201d disorder. Mol Genet Metab. 2004;83(1\u20132):6\u201315.","journal-title":"Mol Genet Metab"},{"key":"627_CR6","volume-title":"GeneReviews\u00ae","author":"GM Pastores","year":"2000","unstructured":"Pastores GM, Hugues DA. Gaucher Disease. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews\u00ae. Seatle: University of Washington; 2000. (Updated 2013 Sep 19) \nhttp:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1269\/\n\n."},{"issue":"18","key":"627_CR7","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000;160(18):2835\u201343.","journal-title":"Arch Intern Med"},{"issue":"8","key":"627_CR8","first-page":"792","volume":"85","author":"P Giraldo","year":"2000","unstructured":"Giraldo P, Pocov\u00ed M, P\u00e9rez-Calvo J, Rubio-F\u00e9lix D, Giralt M. Report of the Spanish Gaucher\u2019s disease registry: clinical and genetic characteristics. Haematologica. 2000;85(8):792\u20139.","journal-title":"Haematologica"},{"issue":"2","key":"627_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","volume":"143","author":"O Goker-Alpan","year":"2003","unstructured":"Goker-Alpan O, Schiffmann R, Park JK, Stubblefield BK, Tayebi N, Sidransky E. Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3. J Pediatr. 2003;143(2):273\u20136.","journal-title":"J Pediatr"},{"issue":"3","key":"627_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK, Morrison A, Lwin A, Colegial C, Allman JM, Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab. 2004;82(3):192\u2013207.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"627_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bcmd.2003.10.010","volume":"32","author":"P Alfonso","year":"2004","unstructured":"Alfonso P, Rodr\u00edguez-Rey JC, Ga\u00f1\u00e1n A, P\u00e9rez-Calvo JI, Giralt M, Giraldo P, Pocov\u00ed M. Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients. Blood Cells Mol Dis. 2004;32(1):218\u201325.","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"627_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10038-007-0135-4","volume":"52","author":"P Alfonso","year":"2007","unstructured":"Alfonso P, Aznarez S, Giralt M, Pocovi M, Giraldo P, Spanish Gaucher\u2019s Disease Registry. Mutation analysis and genotype\/phenotype relationships of Gaucher disease patients in Spain. J Hum Genet. 2007;52(5):391\u20136.","journal-title":"J Hum Genet"},{"issue":"S1","key":"627_CR13","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1002\/ajh.24063","volume":"90","author":"GA Grabowski","year":"2015","unstructured":"Grabowski GA, Zimran A, Ida H. Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry. Am J Hematol. 2015;90(S1):S12\u20138.","journal-title":"Am J Hematol"},{"issue":"3","key":"627_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","volume":"36","author":"NJ Weinreb","year":"2013","unstructured":"Weinreb NJ, Goldblatt J, Villalobos J, Charrow J, Cole JA, Kerstenetzky M, vom Dahl S, Hollak C. Long-term clinical outcomes in type 1 Gaucher disease following 10\u00a0years of imiglucerase treatment. J Inherit Metab Dis. 2013;36(3):543\u201353.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"627_CR15","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1542\/peds.2007-2144","volume":"122","author":"H Andersson","year":"2008","unstructured":"Andersson H, Kaplan P, Kacena K, Yee J. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1. Pediatrics. 2008;122(6):1182\u201390.","journal-title":"Pediatrics"},{"key":"627_CR16","unstructured":"Gaucher Disease. A strategic collaborative approach from EMA and FDA. European Medicines Agency 2014;EMA\/44410\/2014. \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2014\/05\/WC500166587.pdf\n\n."},{"issue":"6","key":"627_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10545-014-9693-8","volume":"37","author":"LJ Anderson","year":"2014","unstructured":"Anderson LJ, Henley W, Wyatt KM, Nikolaou V, Waldek S, Hughes DA, Pastores GM, Logan S. Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study. J Inherit Metab Dis. 2014;37(6):961\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"627_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jpeds.2007.02.057","volume":"151","author":"G Drelichman","year":"2007","unstructured":"Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease. J Pediatr. 2007;151(2):197\u2013201.","journal-title":"J Pediatr"},{"key":"627_CR19","doi-asserted-by":"publisher","first-page":"A37","DOI":"10.1259\/bjr.75.suppl_1.750037","volume":"75S1","author":"B Bembi","year":"2002","unstructured":"Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ. Bone complications in children with Gaucher disease. Br J Radiol. 2002;75S1:A37\u201344.","journal-title":"Br J Radiol"},{"issue":"1","key":"627_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10545-006-0121-6","volume":"29","author":"A El-Beshlawy","year":"2006","unstructured":"El-Beshlawy A, Ragab L, Youssry I, Yakout K, El-Kiki H, Eid K, Mansour IM, Abd El-Hamid S, Yang M, Mistry PK. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients. J Inherit Metab Dis. 2006;29(1):92\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"627_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/PL00008411","volume":"160","author":"H Ida","year":"2001","unstructured":"Ida H, Rennert OM, Kobayashi M, Eto Y. Effects of enzyme replacement therapy in thirteen Japanese paediatric patients with Gaucher disease. Eur J Pediatr. 2001;160(1):21\u20135.","journal-title":"Eur J Pediatr"},{"issue":"4 Suppl 5","key":"627_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","volume":"41","author":"GM Pastores","year":"2004","unstructured":"Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, Grabowski GA, Mistry PK, Tylki-Szyma\u0144ska A. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol. 2004;41(4 Suppl 5):4\u201314.","journal-title":"Semin Hematol"},{"issue":"4","key":"627_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00431-012-1771-z","volume":"172","author":"P Kaplan","year":"2013","unstructured":"Kaplan P, Baris H, De Meirleir L, Di Rocco M, El-Beshlawy A, Huemer M, Martins AM, Nascu I, Rohrbach M, Steinbach L, Cohen IJ. Revised recommendations for the management of Gaucher disease in children. Eur J Pediatr. 2013;172(4):447\u201358.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"627_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcmd.2009.12.002","volume":"44","author":"CE Hollak","year":"2010","unstructured":"Hollak CE, Aerts JM, Belmatoug N, Bembi B, Bodamer O, Cappellini D, Collin-Histed T, Cox TM, Deegan P, Giraldo P, Hughes D, Lukina E, Manuel J, Michelakakis H, Di Rocco M, Vellodi A, Zimran A. Guidelines for the restart of imiglucerase in patients with Gaucher disease: recommendations from the European Working Group on Gaucher disease. Blood Cells Mol Dis. 2010;44(2):86\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"627_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","volume":"31","author":"TM Cox","year":"2008","unstructured":"Cox TM, Aerts JM, Belmatoug N, Cappellini MD, vom Dahl S, Goldblatt J, Grabowski GA, Hollak CE, Hwu P, Maas M, Martins AM, Mistry PK, Pastores GM, Tylki-Szymanska A, Yee J, Weinreb N. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis. 2008;31(3):319\u201336.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"627_CR26","first-page":"158","volume":"32","author":"SS Raghavan","year":"1980","unstructured":"Raghavan SS, Topol J, Kolodny EH. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. Am J Hum Genet. 1980;32(2):158\u201373.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"627_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","volume":"4","author":"M Horowitz","year":"1989","unstructured":"Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989;4(1):87\u201396.","journal-title":"Genomics"},{"key":"627_CR28","doi-asserted-by":"publisher","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 1994;93(3):1288-92.","DOI":"10.1172\/JCI117084"},{"key":"627_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","volume":"103","author":"RG Boot","year":"2004","unstructured":"Boot RG, Verhoek M, de Fost M, et al. Marked elevation of the Chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood. 2004;103:33\u20139.","journal-title":"Blood"},{"issue":"1","key":"627_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00431-012-1830-5","volume":"172","author":"S Kallish","year":"2013","unstructured":"Kallish S, Kaplan P. A disease severity scoring system for children with type 1 Gaucher disease. Eur J Pediatr. 2013;172(1):39\u201343.","journal-title":"Eur J Pediatr"},{"issue":"8","key":"627_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.20908","volume":"82","author":"PK Mistry","year":"2007","unstructured":"Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82(8):697\u2013701.","journal-title":"Am J Hematol"},{"issue":"4","key":"627_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bjh.12804","volume":"165","author":"AS Thomas","year":"2014","unstructured":"Thomas AS, Mehta A, Hughes DA. Gaucher disease: haematological presentations and complications. Br J Haematol. 2014;165(4):427\u201340.","journal-title":"Br J Haematol"},{"key":"627_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1172-9-51","volume":"9","author":"L Dussen van","year":"2014","unstructured":"van Dussen L, Biegstraaten M, Hollak CE, Dijkgraaf MG. Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease. Orphanet J Rare Dis. 2014;9:51.","journal-title":"Orphanet J Rare Dis"},{"key":"627_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13023-014-0112-x","volume":"9","author":"L Dussen van","year":"2014","unstructured":"van Dussen L, Biegstraaten M, Dijkgraaf MG, Hollak CE. Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications. Orphanet J Rare Dis. 2014;9:112.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"627_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","volume":"46","author":"PK Mistry","year":"2011","unstructured":"Mistry PK, Weinreb NJ, Kaplan P, Cole JA, Gwosdow AR, Hangartner T. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. Blood Cells Mol Dis. 2011;46(1):66\u201372.","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"627_CR36","first-page":"683","volume":"16","author":"S Bronstein","year":"2014","unstructured":"Bronstein S, Karpati M, Peleg L. An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H. Isr Med Assoc J. 2014;16(11):683\u20135.","journal-title":"Isr Med Assoc J"},{"key":"627_CR37","volume-title":"Children with type 1 Gaucher disease: changing profiles in the 21st century","author":"G Alterescu","year":"2016","unstructured":"Alterescu G, Abrahamov A, Elstein, Zimran A. Children with type 1 Gaucher disease: changing profiles in the 21st century. Zaragoza: 12th European Working Group on Gaucher Disease Congress; 2016."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T08:35:09Z","timestamp":1493800509000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0627-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0627-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]},"article-number":"84"}}